Ramsay Health Care Ltd

Healthcare AU RHC

37.63AUD
-0.79(2.06%)

Last update at 2024-11-13T05:10:00Z

Day Range

37.6338.15
LowHigh

52 Week Range

37.9756.26
LowHigh

Fundamentals

  • Previous Close 38.42
  • Market Cap8841.60M
  • Volume398536
  • P/E Ratio33.39
  • Dividend Yield2.09%
  • EBITDA1483.00M
  • Revenue TTM16660.20M
  • Revenue Per Share TTM72.91
  • Gross Profit TTM 1646.80M
  • Diluted EPS TTM1.15

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 527.10M 538.50M 741.60M 466.20M 846.83M
Minority interest -67.40000M -105.20000M 518.10M 483.40M 479.40M
Net income 298.10M 274.00M 449.00M 284.00M 545.47M
Selling general administrative 9431.00M 8309.50M 7817.60M 7571.80M 7171.24M
Selling and marketing expenses - - - - -
Gross profit 11515.30M 9974.30M 9339.60M 9209.70M 8920.63M
Reconciled depreciation 989.10M 927.60M 899.40M 893.20M 485.68M
Ebit 800.00M 696.60M 927.00M 591.40M 1023.32M
Ebitda 1789.10M 1624.20M 1826.40M 1484.60M 1508.99M
Depreciation and amortization 989.10M 927.60M 899.40M 893.20M 485.68M
Non operating income net other - - - - -
Operating income 660.30M 460.90M 690.70M 689.00M 1023.32M
Other operating expenses 12671.70M 11411.40M 10816.60M 9873.00M 10572.44M
Interest expense 261.20M 146.80M 163.90M 87.70M 175.89M
Tax provision 181.50M 159.30M 230.10M 157.00M 274.44M
Interest income 514.30M 36.20M 7.10M 407.50M 156.22M
Net interest income -474.30000M -352.80000M -391.00000M -87.70000M -161.61500M
Extraordinary items 19.90M 8.10M 27.70M 2.60M -
Non recurring - - - - -
Other items - - - - -
Income tax expense 181.50M 159.30M 230.10M 157.00M 274.44M
Total revenue 14863.00M 13082.10M 12348.30M 11932.80M 11512.77M
Total operating expenses 10961.10M 9743.70M 9164.80M 8780.00M 7980.30M
Cost of revenue 3347.70M 3107.80M 3008.70M 2723.10M 2592.14M
Total other income expense net 447.20M 660.70M 957.80M 447.80M -176.48500M
Discontinued operations 19.90M 15.30M 15.30M 15.30M -
Net income from continuing ops 345.60M 379.20M 511.50M 309.20M 572.39M
Net income applicable to common shares 285.10M 265.00M 439.90M 272.70M 532.70M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 21342.40M 21030.20M 19473.30M 19324.60M 18058.70M
Intangible assets - 407.30M 435.20M 467.30M 462.70M
Earning assets - - - - -
Other current assets 308.50M 28.30M 24.50M 1990.50M 39.20M
Total liab 15814.90M 16207.00M 14947.10M 14773.80M 13822.80M
Total stockholder equity 4897.60M 4154.80M 3933.50M 4032.70M 3752.50M
Deferred long term liab - - - - -
Other current liab 1827.20M 2326.10M 2264.10M 2552.60M 2624.30M
Common stock 2246.80M 2148.60M 2125.20M 2120.90M 2119.40M
Capital stock - 2400.80M 2377.40M 2373.10M 2371.60M
Retained earnings 2500.20M 1786.70M 1708.70M 1750.90M 1431.90M
Other liab - 997.10M 920.40M 901.60M 867.90M
Good will 5744.90M 5756.40M 5363.80M 3766.30M 3783.40M
Other assets - 719.00M 669.20M 622.00M 498.30M
Cash 662.30M 656.10M 314.20M 1004.80M 1503.70M
Cash and equivalents - - 314.20M 1004.80M 1503.70M
Total current liabilities 4180.30M 3810.40M 3725.60M 3717.20M 3772.90M
Current deferred revenue 95.60M -486.80000M -412.10000M -419.90000M -380.10000M
Net debt 10275.80M 11230.20M 10384.50M 9546.90M 8013.30M
Short term debt 605.70M 486.80M 397.60M 419.90M 380.10M
Short long term debt - 69.90M 42.80M 51.70M 32.30M
Short long term debt total 10938.10M 11886.30M 10698.70M 10551.70M 9517.00M
Other stockholder equity 2183.80M -4003.10000M -3906.30000M -3948.50000M -3629.50000M
Property plant equipment - 10187.20M 9434.60M 8900.10M 8925.10M
Total current assets 3872.80M 3895.80M 3286.70M 5351.40M 4060.80M
Long term investments - 83.60M 338.90M 300.40M 328.40M
Net tangible assets - -2261.10000M -2117.70000M -453.10000M -745.80000M
Short term investments - 64.50M 11.30M -82.90000M -82.60000M
Net receivables 2522.60M 2266.90M 2331.30M 1801.40M 1916.90M
Long term debt - 5861.50M 5173.50M 5229.00M 4195.50M
Inventory 379.40M 388.60M 376.80M 409.40M 411.00M
Accounts payable 1651.80M 1484.30M 1476.00M 1164.60M 1148.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2285.40000M -32.70000M -152.60000M -91.30000M -51.00000M
Additional paid in capital - - - - -
Common stock total equity - - - - 2119.40M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - -76.70000M -78.20000M
Accumulated amortization - - - - -
Non currrent assets other 475.70M 256.20M 135.40M 81.50M 89.20M
Deferred long term asset charges - - - - -
Non current assets total 17469.60M 17134.40M 16186.60M 13973.20M 13997.90M
Capital lease obligations - 5954.90M 5482.40M 5271.00M 5289.20M
Long term debt total - - 10301.10M 10131.80M 9136.90M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -713.80000M 30.00M -0.70000M -31.90000M -31.90000M
Change to liabilities 102.80M 124.70M 107.10M 890.50M 164.40M
Total cashflows from investing activities -713.80000M 30.00M -2504.20000M -656.00000M -1752.30000M
Net borrowings -3.60000M -1037.80000M 735.90M -1363.90000M 783.40M
Total cash from financing activities -242.40000M -1410.90000M 584.00M -231.90000M 812.04M
Change to operating activities -89.20000M -31.80000M 43.70M -51.60000M -15.00000M
Net income 298.10M 274.00M 449.00M 284.00M 545.47M
Change in cash 341.90M -690.60000M -498.90000M 758.20M -25.11600M
Begin period cash flow 314.20M 1004.80M 1503.70M 745.50M 770.57M
End period cash flow 656.10M 314.20M 1004.80M 1503.70M 745.45M
Total cash from operating activities 1279.60M 715.50M 1481.20M 1680.70M 903.29M
Issuance of capital stock - - - 1476.90M -
Depreciation 962.30M 906.90M 884.00M 875.10M 485.68M
Other cashflows from investing activities 7.10M 1972.20M -1916.60000M 47.30M 9.00M
Dividends paid -236.80000M -371.00000M -125.10000M -335.10000M 321.35M
Change to inventory -14.20000M 28.20M -11.40000M -84.00000M -19.60000M
Change to account receivables 118.20M -664.80000M -103.90000M -268.10000M -299.60000M
Sale purchase of stock - - 0.00000M -9.80000M 349.94M
Other cashflows from financing activities 2463.60M 4733.50M 5882.50M 858.40M -80.17300M
Change to netincome -32.20000M 72.70M 67.60M 16.10M 6.00M
Capital expenditures 720.90M 708.50M 628.90M 680.60M 593.79M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 104.00M -636.60000M -115.30000M -352.10000M -
Stock based compensation 8.00M 13.00M 11.70M -6.60000M -
Other non cash items 19.20M -465.40000M 148.20M 521.60M -1031.15100M
Free cash flow 558.70M 7.00M 852.30M 1000.10M 309.50M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RHC
Ramsay Health Care Ltd
-0.79 2.06% 37.63 33.39 28.57 0.53 1.85 1.17 10.70
RHCPA
Ramsay Health Care Ltd Pref
-0.13 0.12% 105.00 64.82 - 0.85 - - -
SNZ
Summerset Group Holdings Ltd
-0.08 0.69% 11.44 7.24 - 9.11 1.10 24.28 15.54
REG
Regis Healthcare Ltd
-0.27 4.06% 6.38 - 24.39 1.90 259.34 1.88 9.98
OCA
Oceania Healthcare Ltd
0.005 0.76% 0.66 16.25 - 1.90 0.51 4.53 18.97

Reports Covered

Stock Research & News

Profile

Ramsay Health Care Limited owns and operates hospitals in Australia, and internationally. The company offers health care services to public and private patients. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

Ramsay Health Care Ltd

126 Phillip Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Craig Ralph McNally CEO, MD & Exec. Director 1961
Mr. Martyn J. Roberts Group Chief Financial Officer 1968
Ms. Kelly Hibbins Group Head of Investor Relations NA
Ms. Henrietta Rowe BECON, L.L.B. Group Gen. Counsel & Company Sec. NA
Ms. Colleen Harris Group Chief People Officer 1969
Mr. Andrew Wearne Global Chief Audit Exec. NA
Dr. Andrew Jones Group Chief Growth Officer 1974
Sir Edward Byrne AC, DSc, FMEDSCI, FRACP, FRCP, FTSE, M.D., MBA Group Chief Medical Officer 1952
Mr. Kah Peng Hong Group Chief Exec. Officer of Ramsay Sime Darby Health Care 1973
Doug Meagher CFO of Ramsay Australia NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.